These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 912764

  • 21. Serologically defined, unique surface antigen on a mouse mammary adenocarcinoma.
    Kuzumaki N, Klein G.
    J Natl Cancer Inst; 1979 Mar; 62(3):619-22. PubMed ID: 84092
    [Abstract] [Full Text] [Related]

  • 22. Splenic alterations during mammary tumorigenesis: diverse effects on different immune parameters.
    Paul RD, Ghaffar A, Sigel MM, Charyulu V, Lopez DM.
    Anticancer Res; 1981 Mar; 1(2):63-9. PubMed ID: 6214206
    [Abstract] [Full Text] [Related]

  • 23. [Immunological tumor--host relationships in mice].
    Müller M, Welcker ER, Schlotterhoss I, Henker J.
    Allerg Asthma (Leipz); 1969 Mar; 15(3):157-62. PubMed ID: 4906036
    [No Abstract] [Full Text] [Related]

  • 24. Transplantability and antigenicity of two sublines of the TA3 tumor.
    Sanford BH, Codington JF, Jeanloz RW, Palmer PD.
    J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
    [No Abstract] [Full Text] [Related]

  • 25. Properties of spontaneous rat mammary carcinoma CaM-LEW. II. Karyological characteristics and antigenic properties of CaM-LEW tumour, long term passaged in vivo and in vitro.
    Krenová D, Kren V, Stark O.
    Neoplasma; 1969 May; 16(5):523-30. PubMed ID: 5364147
    [No Abstract] [Full Text] [Related]

  • 26. Transplantable mammary tumors in Wistar/Furth rats: development, antigenicity, and effect of hormone manipulations.
    Piessens WF, Churchill WH.
    J Natl Cancer Inst; 1977 Sep; 59(3):911-8. PubMed ID: 408505
    [Abstract] [Full Text] [Related]

  • 27. Central problems in tumor immunology, 1976.
    Weiss DW.
    Isr J Med Sci; 1976 Sep; 12(4-5):281-7. PubMed ID: 1084878
    [No Abstract] [Full Text] [Related]

  • 28. The finding of viral particles in spontaneous mammary adenocarcinoma in rats.
    Domina F, Gimbo A, Licata A.
    Experientia; 1973 Feb 15; 29(2):200-1. PubMed ID: 4348194
    [No Abstract] [Full Text] [Related]

  • 29. Suppressor lymphokine produced by rat T-cells in response to syngeneic mammary adenocarcinoma 13762A.
    Christensen ND, Kreider JW, Horetsky RL.
    Cancer Res; 1988 Feb 15; 48(4):943-9. PubMed ID: 2962735
    [Abstract] [Full Text] [Related]

  • 30. [MA891--an established spontaneous mouse mammary adenocarcinoma cell line and its immunologic characteristics].
    Zhou Y, Luo L, Liu X, Gao P, Su Y.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug 15; 19(4):273-7. PubMed ID: 10453566
    [Abstract] [Full Text] [Related]

  • 31. Systemic adoptive transfer of immunity to 13762A rat mammary adenocarcinoma.
    Boyer CM, Kreider JW, Bartlett GL.
    Cancer Res; 1981 Jun 15; 41(6):2394-400. PubMed ID: 6972251
    [Abstract] [Full Text] [Related]

  • 32. Circulating immune complexes in rats bearing 6-thioguanine-resistant variants of the 13762 mammary adenocarcinoma.
    Hoon DB, Ziola B, Ramshaw I.
    Cancer Res; 1984 Jun 15; 44(6):2406-9. PubMed ID: 6722781
    [Abstract] [Full Text] [Related]

  • 33. Tumor-specific suppressor cells induced by immunization with spleen cells from tumor-bearing animals.
    Huber SA, Bigi G, Lucas ZJ.
    Cancer Res; 1980 Oct 15; 40(10):3477-83. PubMed ID: 6449281
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of effector cell functions in natural killer cell activity (NK) and antibody-dependent cellular cytotoxicity (ADCC) in mice by normal and cancer sera.
    Nair PN, Fernandes G, Onoe K, Day NK, Good RA.
    Int J Cancer; 1980 May 15; 25(5):667-77. PubMed ID: 7372374
    [No Abstract] [Full Text] [Related]

  • 35. Rat mammary adenocarcinoma 13762 expressing IFN-gamma elicits antitumor CD4+ MHC class II-restricted T cells that are cytolytic in vitro and tumoricidal in vivo.
    Frey AB.
    J Immunol; 1995 May 01; 154(9):4613-22. PubMed ID: 7722313
    [Abstract] [Full Text] [Related]

  • 36. Depression of murine macrophage accumulation by low-molecular-weight derived from spontaneous mammary carcinomas.
    Cianciolo GJ, Herberman RB, Snyderman R.
    J Natl Cancer Inst; 1980 Oct 01; 65(4):829-34. PubMed ID: 6932531
    [Abstract] [Full Text] [Related]

  • 37. An innate host response to the neoplastic cell: syngeneic rat tumor cells can elicit a rapid de novo lymphoid procoagulant response.
    Lando PA, Edgington TS.
    J Immunol; 1985 Nov 01; 135(5):3587-95. PubMed ID: 4045197
    [Abstract] [Full Text] [Related]

  • 38. Effect of immune manipulation on natural immune responses to murine mammary tumor antigens.
    Blair PB, Lane MA.
    J Natl Cancer Inst; 1977 Jul 01; 59(1):251-7. PubMed ID: 195069
    [Abstract] [Full Text] [Related]

  • 39. Synergy in proliferative and cytotoxic responses of WF rats to syngeneic Gross virus-induced lymphoma cells in vitro.
    Wright PW, Loop SM, Bernstein ID.
    J Natl Cancer Inst; 1980 Feb 01; 64(2):303-8. PubMed ID: 6965510
    [Abstract] [Full Text] [Related]

  • 40. Immune response to a mammary adenocarcinoma. VI. Blocking of tumor-specific cell-mediated cytotoxicity by antibodies to the cytotoxic lymphocyte.
    Huber SA, Lucas ZJ.
    J Immunol; 1978 Dec 01; 121(6):2490-6. PubMed ID: 309904
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.